To the best of our knowledge, this is the first report in the literature assessing and comparing the profile of immune cell subtypes, including the CD14++CD16+ proinflammatory monocyte subpopulation, NK cells, and lymphocyte subpopulations between patients with CRS-2 and patients with CKD but without established CVD. The gene discussed is CD14; the disease is chronic kidney disease.